A nuclear medicine infusion system (10) may be used to generate and infuse radioactive liquid into a patient undergoing a diagnostic imaging procedure. In some examples, the infusion system includes a frame (30) that carries a radioisotope generator (52) that generates radioactive eluate via elution. The frame may also carry a beta detector (58) and a gamma detector (60). The beta detector can be positioned to measure beta emissions emitted from the radioactive eluate supplied by the generator. The gamma detector can be positioned to measure gamma emissions emitted from a portion of the radioactive eluate to evaluate a safety of the radioactive eluate delivered by the infusion system.

An apparatus (100) and a method for a point of care drug product delivery are provided. A point of care drug product delivery apparatus includes a central interface member (110) that serves as an interface between a saline source, a drug product source, and an infusion line. The central interface member facilitates priming the infusion line with saline from the saline source, infusing drug product to a patient from the drug product source, and flushing the infusion line with saline from the saline source. According to aspects of the current subject matter, the central interface member provides and/or forms fluidic connections and/or passageways between various ones of the saline source, the drug product source, and the infusion line.

Modules for housing electronic and electromechanical medical equipment including a system to measure and record administration of one or more IV medications or fluids for IV administration.

Methods and systems for configuring a plurality of infusion pumps according to a functional set. A method includes implementing a plurality of infusion pumps, each of the infusion pumps configured to administer medication to a patient, implementing a drug library, the drug library including at least one functional set defining a set of medications, receiving input data related to one of the at least one functional sets, obtaining a particular set of medications from the drug library corresponding to the input data, programming the plurality of infusion pumps according to the set of medications, and infusing the patient with the plurality of infusion pumps.

A multi-tubing intravenous (IV) extension set may include an outlet tubing fluidly coupled to a primary multi-tubing connector at one end and fluidly coupled to a vascular device at an opposite end, and a primary inlet tubing having a proximal end with an adapter for connection to a syringe containing a priming or a medicinal fluid, and a distal end coupled to the primary multi-tubing connector. The IV extension set may further include at least one secondary inlet tubing with a proximal end having an adapter for receiving a medicinal fluid and a distal end selectively fluidly coupled to the primary multi-tubing connector. A slide clamp may be positioned on the outlet tubing to restrict flow between the proximal and distal ends of the outlet tubing and cause priming fluid flowing into the outlet tubing via the multi-tubing connector to reverse direction into the at least one secondary inlet tubing.

An infusion system to provide concurrent TPN/insulin infusion including: a fluid administration set having a primary line in fluid communication with the TPN source, a secondary line in fluid communication with the insulin source, and a common outlet line; a pump operable to removably receive the fluid administration set, the pump being operable to concurrently move the TPN solution through the primary line in response to a TPN solution flow rate signal and the insulin solution through the secondary line in response to an insulin solution flow rate signal; and a flow controller operable to provide the TPN solution flow rate signal and the insulin solution flow rate signal to the pump. The flow controller is further operable to vary the TPN solution flow rate signal and the insulin solution flow rate signal to vary a ratio of TPN solution to insulin solution provided to the common outlet line.

A syringe retaining element protruding radially outward relative to an outer surface of a sidewall of a barrel of a syringe is described. The syringe retaining element is configured for interacting with a locking mechanism of a syringe port of a fluid injector to releasably retain the ring. Features of the syringe retaining element allow the syringe to be axially ejected from the syringe port upon rotation of the syringe. Other features of the syringe retaining element allow the syringe to engage the locking mechanism of the syringe port and rotationally guide the syringe into self-orienting alignment with the locking mechanism.

The present invention relates to a method for enabling hospitals or clinics to administer a dose of a drug to patients in need thereof while avoiding steps of manipulation, dilution, reconstitution, dispensing, sterilization, transfer, handling or compounding before intravenous administration. The present invention further relates to a perfusion system comprising different sets of perfusion containers, each container comprising a ready-to-infuse, stable, sterile, aqueous perfusion solution of a drug, wherein the set of perfusion containers alone or in combination provides for direct intravenous administration of a desired dose of the drug to a patient in need thereof, such that the delivered dose is equal to or within ±5% of the calculated dose.

A system automatically calculates drug infusion applicable to a patient to induce a satisfactory anesthetic state during surgery. The automatic calculation system would be determined by target values of physiological monitors to evaluate the patient's condition. Automatic infusion increases patient safety, reducing post-surgical morbidity and mortality, and reduces continuous decision-making by the specialist. An electronic system implements a MIMO-PID controller that calculates the infusion of various drugs on the basis of a control error defined by deviations in the patient's condition, which is analyzed by several monitors. The automatic drug infusions are determined by safety systems for preventing under and/or over infusion events and are complemented with correction and feedback systems.